Skip to content

FlexiOH® as Definitive Cast for Immobilization of Forearm Fracture.

A Prospective, Open-label, Randomized, Clinical Trial of Light Cured Limb Orthosis - FlexiOH® as Definitive Cast for Immobilization of Forearm Fractures in Emergency Settings - NA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036387
Enrollment
300
Registered
2021-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S529- Unspecified fracture of forearm

Interventions

Intervention1: Flexi-OH -Short Arm Immobilizer: FlexiOH® intended to immobilize the injured body parts as orthopaedic cast for external mechanical supportand Clinical Evaluation Study Control Interve

Sponsors

JC OrthoHeal Private Limited
Lead Sponsor
SMO Clinical Research I Private Limited
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male or female aged 18 to 80 years (both inclusive) 2.Subjects with closed fracture of distal end of radius and/or Ulna not requiring internal or external fixation of the fracture belonging to following AO classification: AO CLASSIFICATIONS Distal radius i.Extraarticular ii.2R3A1 Radial styloid avulsion iii.2R3A2 Simple Distal Ulnar fracture i.2U3A1 Styloid process ii.2U3A2 Simple 3.Radiological features following above AO classification 4.Subjects able to provide written informed consent 5.Subjects able to comply with the study procedures

Exclusion criteria

Exclusion criteria: 1.Presence of wound involving deeper tissues or requiring suturing 2.Ulceration or any skin conditions present at the wrist that may interfere with the study 3.Open wound along with fracture or fracture requiring internal fixation 4.Subjects scheduled for surgical management 5.Patients with other co morbid conditions, such as, osteomyelitis, severe dementia, or rheumatoid arthritis 6.Known skin allergy and skin diseases 7.Mentally challenged patients

Design outcomes

Primary

MeasureTime frame
1.Average time required for the fracture to heal completely in all the arms at the end of treatment determined by X-rays. a.X-ray features to diagnose /conclude that bone fracture has been healed. 2.Comparison of all three arms with respect to indices.i.e. �Cast index �Padding index �Gap index 3.Assessment of clinical efficacy scoring obtained by list of questionnaires compared between FlexiOH®, Fiberglass and POP. 4.Assessment of usability scoring compared between FlexiOH® Fiberglass and POP Timepoint: 6-8 weeks

Secondary

MeasureTime frame
1. Incidence of any of the following complication i. Development of swelling ii. Continuous numbness iii. Increasing pain iv. Continuous discomfort v. Skin infections Timepoint: 6-8 weeks

Countries

India

Contacts

Public ContactMr Shreyash Padhiyar

Guru Gobind Singh Government Hospital

drvijayedu@gmail.com9427775057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026